Broadcom acquires NetLogic Microsystems

Broadcom acquires NetLogic Microsystems

Broadcom Corporation (Nasdaq: BRCM), a global innovation leader in semiconductor solutions for wired and wireless communications, and NetLogic Microsystems, Inc. (Nasdaq: NETL), a leader in high performance intelligent semiconductor solutions for next generation networks, recently announced they have entered into a definitive merger agreement.

HP to Acquire 3Com for $2.7 Billion

HP to Acquire 3Com for $2.7 Billion

HP and 3Com Corporation (NASDAQ: COMS) (“3Com”) announced that they have entered into a definitive agreement under which HP will purchase 3Com, a leading provider of networking switching, routing and security solutions, at a price of $7.90 per share in cash or an enterprise value of approximately $2.7 billion.

Roche completes tender offer for Genentech

Roche completes tender offer for Genentech

Roche (SWX: ROG.VX; RO.S, OTCQX: RHHBY) announced that its wholly-owned subsidiary, Roche Investments USA Inc., completed its tender offer for the publicly held shares of Genentech (NYSE: DNA).

Autism :: Adolescence and autism – a difficult, but not hopeless, combination according to a new MUHC study

The challenges that autistic patients face become more pronounced during adolescence, a crucial period when many kinds of social behaviours are developed and when these individuals can become more keenly aware of their relationship difficulties. A paper by Dr. Eric Fombonne, Head of the Division of Child Psychiatry at the McGill University Health Centre (MUHC), published in the November 2007 issue of the Journal of Autism and Developmental Disorders describes the effectiveness of social skills training groups for autistic adolescents.

Acne :: A new angle to treat hard-to-reach acne

There is a new angle of attack on body acne in places that are hard-to-reach and treat, such as the back. ClindaReach?, a revolutionary easy to use treatment that packages a topical antibiotic with an ergonomically designed applicator to treat hard-to-reach acne, was launched this week by DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA).

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack